Mauritania vs Rwanda: Access to anti-retroviral drugs, male
Mauritania
97.0%
in 2024
Rwanda
95.0%
in 2024
Mauritania rank
2nd
Rwanda rank
4th
Access to anti-retroviral drugs, male over time
- Mauritania
- Rwanda
How they compare
Mauritania currently reports 97.0% against 95.0% in Rwanda, a difference of 2.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Rwanda ahead.
Mauritania ranks 2nd and Rwanda ranks 4th of 141 countries.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mauritania | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.7% | 10.4% | 6.7% | Rwanda |
| 2010s | 33.4% | 60.0% | 26.6% | Rwanda |
| 2020s | 79.4% | 90.0% | 10.6% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Mauritania or Rwanda?
- Mauritania, at 97.0% against 95.0% in Rwanda as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Mauritania and Rwanda?
- 2.0%, with Mauritania ahead.
- How many years of comparable data are there for Mauritania and Rwanda?
- 25 years are reported by both, from 2000 to 2024.
- How do Mauritania and Rwanda rank globally for access to anti-retroviral drugs, male?
- Mauritania ranks 2nd and Rwanda ranks 4th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.